Kolexia
Deandreis Desiree
Médecine nucléaire
Gustave-Roussy
Villejuif, France
177 Activités
676 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la thyroïde Carcinomes Métastase tumorale Tumeurs de la prostate Récidive tumorale locale Tumeurs neuroendocrines Carcinome anaplasique de la thyroïde Métastase lymphatique Tumeurs osseuses

Industries

ADVANCED ACCELERATOR APPLICATIONS
2 collaboration(s)
Dernière en 2023
IMMEDICA PHARMA FRANCE SARL
2 collaboration(s)
Dernière en 2023
Spectrum Dynamics
1 collaboration(s)
Dernière en 2023
MARKET ACCESS TRANSFORMATION
1 collaboration(s)
Dernière en 2023

Dernières activités

Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   11 janvier 2024
Comparison of Digital versus Analog Ga-PSMA-11 PET/CT Performance in Hormone-Sensitive Prostate Cancer Patients with Early Biochemical Recurrence or Persistence after Radical Treatment.
Diagnostics (Basel, Switzerland)   26 novembre 2023
The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study.
Clinical genitourinary cancer   17 novembre 2023
Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer: A Pilot Study.
Diagnostics (Basel, Switzerland)   21 septembre 2023
Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer.
Cancers   27 août 2023
Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice.
European thyroid journal   08 août 2023
Applications of Artificial Intelligence and Radiomics in Molecular Hybrid Imaging and Theragnostics for Neuro-Endocrine Neoplasms (NENs).
Life (Basel, Switzerland)   28 juillet 2023
Artificial Intelligence in Breast Cancer: A Systematic Review on PET Imaging Clinical Applications.
Current medical imaging   22 mai 2023
The Role of Theragnostics in Breast Cancer: A Systematic Review of the Last 12 Years.
Current medical imaging   22 mai 2023
Can Baseline FFDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study.
Cancer biotherapy & radiopharmaceuticals   25 avril 2023